Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Kyverna Therapeutics Inc. (NASDAQ : KYTX ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna¿s pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases.
Quote
| Last: | $9.30 |
|---|---|
| Change Percent: | 4.14% |
| Open: | $8.99 |
| Close: | $8.93 |
| High: | $9.4299 |
| Low: | $8.9 |
| Volume: | 311,957 |
| Last Trade Date Time: | 04/13/2026 12:42:53 pm |
Stock Data
| Market Cap: | $448,450,247 |
|---|---|
| Float: | 32,219,865 |
| Insiders Ownership: | 0.32% |
| Institutions: | 24 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.kyvernatx.com |
| Country: | US |
| City: | Emeryville |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Kyverna Therapeutics Inc. (NASDAQ: KYTX).
